IMRIS has received the US Food and Drug Administration (FDA) clearance for its next-generation VISIUS surgical theatre equipped with Siemens‘ latest high-field MR scanners.

The next-generation surgical theatre provides surgeons with on-demand access to real-time data and state-of-the-art imaging, during the procedure from the OR table.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Using Siemens Aera 1.5T (tesla) and Skyra 3.0T technology the IMRIS deliver better image quality with higher signal-to-noise ratio, faster 3D image acquisition, and improved ease-of-use and workflow during neurosurgical procedures using intraoperative MRI (iMRI).

IMRIS president and CEO Jay D Miller said: "We are bringing the latest and unequalled imaging technology into the operating room where it can make the most difference during the surgery.

"IMRIS systems have been used in over 13,000 cases worldwide to improve outcomes in brain tumour and epilepsy surgeries in particular."

The addition of these MR systems expands the 1.5T and 3.0T MRI choices hospitals have when considering the unique, ceiling-mounted IMRIS solution for intraoperative imaging which brings the MRI to the patient during the procedure.

"IMRIS systems have been used in over 13,000 cases worldwide to improve outcomes in brain tumour and epilepsy surgeries in particular."

The first installation of this new generation VISIUS Surgical Theatre will be a four-room hybrid operating room suite, known as the Center for Surgical Innovation (CSI) at Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire.

Dartmouth – Hitchcock medical director of CSI and chair of orthopaedics Dr Sohail Mirza said: "The advanced integration of state-of-the-art imaging tools in CSI will allow surgeons and engineers to innovate like never before, rapidly developing, testing, and validating new surgical tools and techniques, with the goal of achieving better, safer, and, in some cases, less-costly care for patients everywhere."

The Dartmouth – Hitchcock installation will also include a VISIUS intraoperative CT (iCT), which uses the technology of the 64-slice Siemens SOMATOM Definition AS scanner, making it the only operating suite in the world with both VISIUS iMRI and iCT modalities able to serve multiple operating rooms (ORs) without moving the patient.

IMRIS also designs and manufactures proprietary head fixation devices, imaging coils, and OR tables for use in this unique and multifunctional intraoperative environment.

Image: The next-generation VISIUS surgical theatre. Photo: courtesy of IMRIS Inc./CNW Group.